These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22620282)

  • 1. Wound debridement potential of glycosidases of the wound-healing maggot, Lucilia sericata.
    Telford G; Brown AP; Rich A; English JS; Pritchard DI
    Med Vet Entomol; 2012 Sep; 26(3):291-9. PubMed ID: 22620282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blow fly Lucilia sericata nuclease digests DNA associated with wound slough/eschar and with Pseudomonas aeruginosa biofilm.
    Brown A; Horobin A; Blount DG; Hill PJ; English J; Rich A; Williams PM; Pritchard DI
    Med Vet Entomol; 2012 Dec; 26(4):432-9. PubMed ID: 22827809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of eschar from venous leg ulcers using a recombinant chymotrypsin from Lucilia sericata.
    Telford G; Brown AP; Seabra RA; Horobin AJ; Rich A; English JS; Pritchard DI
    Br J Dermatol; 2010 Sep; 163(3):523-31. PubMed ID: 20491762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maggot chymotrypsin I from Lucilia sericata is resistant to endogenous wound protease inhibitors.
    Telford G; Brown AP; Kind A; English JS; Pritchard DI
    Br J Dermatol; 2011 Jan; 164(1):192-6. PubMed ID: 21175562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of MSCRAMM target macromolecules in VLU slough by Lucilia sericata chymotrypsin 1 (ISP) persists in the presence of tissue gelatinase activity.
    Pritchard DI; Brown AP
    Int Wound J; 2015 Aug; 12(4):414-21. PubMed ID: 23834475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maggots as a wound debridement agent for chronic venous leg ulcers under graduated compression bandages: A randomised controlled trial.
    Davies CE; Woolfrey G; Hogg N; Dyer J; Cooper A; Waldron J; Bulbulia R; Whyman MR; Poskitt KR
    Phlebology; 2015 Dec; 30(10):693-9. PubMed ID: 25300315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor.
    Linger RJ; Belikoff EJ; Yan Y; Li F; Wantuch HA; Fitzsimons HL; Scott MJ
    BMC Biotechnol; 2016 Mar; 16():30. PubMed ID: 27006073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maggot debridement therapy in chronic wound care.
    Chan DC; Fong DH; Leung JY; Patil NG; Leung GK
    Hong Kong Med J; 2007 Oct; 13(5):382-6. PubMed ID: 17914145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid derivatives from Lucilia sericata excretions/secretions may contribute to the beneficial effects of maggot therapy via increased angiogenesis.
    Bexfield A; Bond AE; Morgan C; Wagstaff J; Newton RP; Ratcliffe NA; Dudley E; Nigam Y
    Br J Dermatol; 2010 Mar; 162(3):554-62. PubMed ID: 19799603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a cGMP compatible Lucilia sericata insect serine proteinase debridement enzyme.
    Pritchard DI; Telford G; Diab M; Low W
    Biotechnol Prog; 2012; 28(2):567-72. PubMed ID: 22323388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maggot excretion products from the blowfly Lucilia sericata contain contact phase/intrinsic pathway-like proteases with procoagulant functions.
    Kahl M; Gökçen A; Fischer S; Bäumer M; Wiesner J; Lochnit G; Wygrecka M; Vilcinskas A; Preissner KT
    Thromb Haemost; 2015 Aug; 114(2):277-88. PubMed ID: 25948398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular approach to maggot debridement therapy with Lucilia sericata and its excretions/secretions in wound healing.
    Tombulturk FK; Kanigur-Sultuybek G
    Wound Repair Regen; 2021 Nov; 29(6):1051-1061. PubMed ID: 34343386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary evaluation of maggot (Diptera: Calliphoridae) therapy as a potential treatment for leishmaniasis ulcers].
    Arrivillaga J; Rodríguez J; Oviedo M
    Biomedica; 2008 Jun; 28(2):305-10. PubMed ID: 18719732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and partial characterization of antifungal bioactivity from the secretions of the medicinal maggot, Lucilia sericata.
    Evans R; Dudley E; Nigam Y
    Wound Repair Regen; 2015; 23(3):361-8. PubMed ID: 25847128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Maggot therapy with Lucilia sericata for debridement of chronic wounds].
    Cartier E; Combemale P
    Ann Dermatol Venereol; 2008 Oct; 135(10):685-8. PubMed ID: 18929922
    [No Abstract]   [Full Text] [Related]  

  • 16. Next Generation Sequencing Identifies Five Major Classes of Potentially Therapeutic Enzymes Secreted by Lucilia sericata Medical Maggots.
    Franta Z; Vogel H; Lehmann R; Rupp O; Goesmann A; Vilcinskas A
    Biomed Res Int; 2016; 2016():8285428. PubMed ID: 27119084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maggot therapy in wound management].
    Falch BM; de Weerd L; Sundsfjord A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1864-7. PubMed ID: 19844278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Jonah-like chymotrypsin from the therapeutic maggot Lucilia sericata plays a role in wound debridement and coagulation.
    Pöppel AK; Kahl M; Baumann A; Wiesner J; Gökçen A; Beckert A; Preissner KT; Vilcinskas A; Franta Z
    Insect Biochem Mol Biol; 2016 Mar; 70():138-47. PubMed ID: 26773746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does maggot therapy promote wound healing? The clinical and cellular evidence.
    Nigam Y; Morgan C
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):776-82. PubMed ID: 26691053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of maggot therapy on minimally necrotic tissues: characterization of larval enzymatic excretion/secretion].
    Téllez GA; Acero MA; Pineda LA; Castaño JC
    Biomedica; 2012 Sep; 32(3):312-20. PubMed ID: 23715180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.